Do thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease or is this an unanswerable question?

Inflammatory Bowel Diseases

Volumn 18, Issue 6, 2012, Pages 1184-1185

  Devlin, Shane M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE; MESALAZINE;

ANTIINFLAMMATORY ACTIVITY; COLITIS; COLORECTAL TUMOR; DISEASE ASSOCIATION; DYSPLASIA; ENTERITIS; HISTOPATHOLOGY; HUMAN; MULTIVARIATE ANALYSIS; NOTE; PRIORITY JOURNAL; UNIVARIATE ANALYSIS;

EID: 84861329746     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21869     Document Type: Note

References (10)

1. Velayos FS, Terdiman JP, Walsh JM,. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol. 2005; 100: 1345-1353.
2. Bernstein CN, Blanchard JF, Metge C, et al. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol. 2003; 98: 2784-2788.
3. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004; 126: 451-459.
4. Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007; 133: 1099-1105; quiz 1340-1341.
5. Fraser AG, Orchard TR, Robinson EM, et al. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther. 2002; 16: 1225-1232.
6. Matula S, Croog V, Itzkowitz S, et al. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. Clin Gastroenterol Hepatol. 2005; 3: 1015-1021.
7. Tung BY, Emond MJ, Haggitt RC, et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med. 2001; 134: 89-95.
8. Beaugerie L, Seksik P, Bouvier A-M, et al. Thiopurine therapy is associated with a three-fold decrease in the incidence of advanced colorectal neoplasia in IBD patients with longstanding extensive colitis: results from the CESAME cohort. Gastroenterology. 2009; 136: A-54.
9. Carrat F, Seksik P, Bouvier A-M, et al. Aminosalicylates, thiopurines and the risk of colorectal cancer in inflammatory bowel disease: a case-control study nested in the CESAME cohort. Gastroenterology. 2010; 138: S-47.
10. Rubin DT, Lashner BA,. Will a 5-ASA a day keep the cancer (and dysplasia) away? Am J Gastroenterol. 2005; 100: 1354-1356.